CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-08 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +13,100 | 13,100 | ||
| 2017-06-08 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +13,100 | 13,100 | ||
| 2017-05-08 | KIRK RANDAL J 10% owner | Sale | −9,695 | $2.54 | $25K | 440,418 |
| 2017-05-08 | KIRK RANDAL J 10% owner | Sale | −1,881 | $2.54 | $5K | 85,397 |
| 2017-05-05 | KIRK RANDAL J 10% owner | Sale | −71,607 | $2.70 | $193K | 450,113 |
| 2017-05-05 | KIRK RANDAL J 10% owner | Sale | −13,893 | $2.70 | $38K | 87,278 |
| 2017-05-04 | KIRK RANDAL J 10% owner | Option exercise | +250,000 | $0.80 | $200K | 583,334 |
| 2017-05-04 | KIRK RANDAL J 10% owner | Sale | −49,875 | $4.01 | $200K | 533,459 |
| 2017-05-04 | KIRK RANDAL J 10% owner | Sale | −11,739 | $2.97 | $35K | 521,720 |
| 2017-05-04 | KIRK RANDAL J 10% owner | Sale | −2,278 | $2.97 | $7K | 101,171 |
| 2017-05-04 | KIRK RANDAL J 10% owner | Option exercise · Warrant to Purchase Common Stock | −250,000 | 0 | ||
| 2017-03-31 | Straube Richard SVP and CMO | Grant or award · Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-03-31 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +50,000 | 50,000 | ||
| 2017-03-31 | Krumeich Karen R SVP and CFO | Grant or award · Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-03-31 | Donini Oreola SVP and CSO | Grant or award · Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-12-16 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +15,804 | $3.16 | $50K | 25,095 |
| 2016-12-16 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase · Common Stock Warrant | +19,755 | $0.00 | $2 | 19,755 |
| 2016-12-16 | RUBIN ROBERT J. Director | Purchase | +3,165 | $3.16 | $10K | 4,385 |
| 2016-12-16 | RUBIN ROBERT J. Director | Purchase · Common Stock Warrant | +3,956 | $0.00 | $0 | 3,956 |
| 2016-12-16 | Brughera Marco Maria Director | Purchase | +2,000 | $3.16 | $6K | 2,750 |
Page 9 of 14 · 277 trades